Elsevier Inc.

SHERPA: Unknown

People

  1. Scher
    Scher
  2. Slovin
    Slovin
  3. Rosen
    Rosen
  4. Heller
    Heller
  5. Hricak
    Hricak
  6. Morris
    Morris
  7. Myskowski
    Myskowski
  8. Scardino
    Scardino
  9. Schwartz
    Schwartz

Groups

  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Hematologic Malignancies, Division of (5)
  5. GSK Faculty (3)
  6. Molecular Pharmacology and Chemistry Program Faculty (3)
  7. Sloan Kettering Institute Faculty (3)
  8. Breast Medicine Service (2)
  9. Adult Leukemia (1)
  10. Biostatistics Service (1)
Search Within
  1. "Genitourinary Oncology Service"
  2. "William Kelly"
Formats
  1. Journal Article (3)
  2. Conference Paper (2)
  3. Meeting Abstract (2)
Groups
  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Hematologic Malignancies, Division of (5)
  5. GSK Faculty (3)
  6. Molecular Pharmacology and Chemistry Program Faculty (3)

More Groups

People
  1. William Kelly (7)
  2. Howard Scher (6)
  3. Susan Slovin (5)
  4. Neal Rosen (2)
  5. William Tong (2)
  6. Andrew Wilton (1)

More People

Years
  1. 2009 (1)
  2. 2005 (1)
  3. 2004 (1)
  4. 2002 (1)
  5. 2001 (1)
  6. 1996 (2)
Publications
  1. Clinical Prostate Cancer (2)
  2. European Journal of Cancer (2)
  3. Seminars in Oncology (2)
  4. Clinical Genitourinary Cancer (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus doxorubicin in the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Slovin, S. F.; Kelly, W. K.; Wilton, A.; Kattan, M.; Myskowski, P.; Mendelsohn, J.; Scher, H. I.
    Clinical Genitourinary Cancer (2009)

    Fulltext@MSK | Save
  • Second-line chemotherapy for prostate cancer: Patient characteristics and survival
    Journal Article

    Beekman, K. W.; Fleming, M. T.; Scher, H. I.; Slovin, S. F.; Ishill, N. M.; Heller, G.; Kelly, W. K.
    Clinical Prostate Cancer (2005)

    Fulltext@MSK | Save
  • Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse
    Journal Article

    Pucar, D.; Koutcher, J. A.; Shah, A.; Dyke, J. P.; Schwartz, L.; Thaler, H.; Kurhanewicz, J.; Scardino, P. T.; Kelly, W. K.; Hricak, H.; more...
    Clinical Prostate Cancer (2004)

    Fulltext@MSK | Save
  • A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
    Meeting Abstract

    Kelly, W.; O'connor, O.; Richon, V. M.; Tong, W.; Rao, T. D.; Chiao, J.; O'Brien, J. P.; Rifkind, R. A.; Marks, P. A.; Scher, H. I.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer
    Meeting Abstract

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Rosen, N.; Scher, H. I.
    European Journal of Cancer (2001)

    Fulltext@MSK | Save
  • Targeted therapy for prostate cancer: The Memorial Sloan-Kettering Cancer Center approach
    Conference Paper

    Slovin, S. F.; Livingston, P. O.; Rosen, N.; Sepp-Lorenzino, L.; Kelly, W. K.; Mendelsohn, J.; Scher, H. I.
    Elsevier Inc. (1996)

    Fulltext@MSK | Save
  • Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer
    Conference Paper

    Kelly, W. K.; Slovin, S.; Scher, H. I.
    Elsevier Inc. (1996)

    Fulltext@MSK | Save